Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Z Analyzer who wrote (2042)	5/5/1998 6:49:00 AM
From: James Baker	Read Replies (2) \| Respond to of 9523

What does everyone think about a drug with a less than 4% refill rate????? That Viagra in current IMS data. Maybe too early for the 15 pill poppers but those who only got 6? Jim

To: Z Analyzer who wrote (2042)	5/5/1998 9:46:00 AM
From: Perry	Read Replies (1) \| Respond to of 9523

Z Analyzer, your analysis appears to be satisfactory although you make the major mistake that most analyst do and that is that you are assuming that products now on the market, drugs soon to be approved and the strong pipeline are not going to dramatically improve the earnings picture. Viagra will allow PFE to funnel greater amounts of $ to R&D which will again increase the future prospects for PFE. However, all that being said I think in the short term PFE stock price will live or die by the next few months Viagra Rx data and upcoming earnings. I have received my analyst report and they appear quite optimistic regarding PFE's future prospects but I believe a critical factor why brokerage firms are reluctant to upgrade PFE is the lack of guidance by PFE CEO on the future propects of Viagra. Maybe the CEO will make some positive comments at the next earnings release. Good luck. Perry Good luck. Perry